Amsterdam UMC at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

Amsterdam UMC brings 2 presentations to ESGCT 2026 in Hamburg. Its work centres on gene therapy for heart disease and the models used to develop it. One topic is a compact heart-muscle-specific promoter driving a gene pair for biological pacing without implanted hardware.

OrganizationESGCT 2026 Attendance
Amsterdam UMC
Amsterdam, Netherlands
amsterdamumc.org
Hospitals & clinical centres
Dutch university medical centre formed by the AMC and VUmc hospitals in Amsterdam.
Poster
Wed Oct 28
1:30pm–3:30pm
A compact cardiomyocyte-specific bidirectional promoter driving HCN4t/B2AR enables reliable hardware-free biological pacing
Cardiovascular & Muscular diseases
Talk
Fri Oct 30
9:00am–10:30am
Translational Perspective for Cardiac Disease Modeling and Therapy Development.
SESSION 11c: Disease models
Clinical trials and translation

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Amsterdam UMC

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction